Cornercap Investment Counsel Inc Teva Pharmaceutical Industries LTD Transaction History
Cornercap Investment Counsel Inc
- $302 Million
- Q4 2024
A detailed history of Cornercap Investment Counsel Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 39,295 shares of TEVA stock, worth $603,571. This represents 0.29% of its overall portfolio holdings.
Number of Shares
39,295
Previous 41,074
4.33%
Holding current value
$603,571
Previous $740,000
17.03%
% of portfolio
0.29%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding TEVA
# of Institutions
677Shares Held
578MCall Options Held
25.5MPut Options Held
14.7M-
Black Rock Inc. New York, NY43MShares$660 Million0.02% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L339MShares$598 Million7.75% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.7MShares$563 Million48.01% of portfolio
-
Menora Mivtachim Holdings Ltd.28.4MShares$436 Million3.94% of portfolio
-
Exor Capital LLP London, X027.2MShares$418 Million17.5% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $17.1B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...